Genetics manipulations with recombinant DNA virus comprising sequences derived from RNA virus
AssigneesAveve N.V., Clovis Matton
InventorsEddie Van Haute, Paul Ameloot, Jean De Lafonteyne, Walter Fiers
Life of this patent
Estimating the term…
Loading patent…
AssigneesAveve N.V., Clovis Matton
InventorsEddie Van Haute, Paul Ameloot, Jean De Lafonteyne, Walter Fiers
Estimating the term…
The invention relates to genetic manipulations of eukaryotic organisms, with recombinant DNA comprising RNA virus derived sequences for protecting such organisms against RNA viruses or enabling inducible or tissue-specific production of foreign proteins/peptides or RNAs. One embodiment of the recombinant DNA according to the invention comprises recombinant DNA, comprising two, 12-250 base pair long, inverted repeat nucleotide sequences with therebetween at least one nucleotide sequence which is derived from RNA virus which for its replication is dependent upon a viral RNA/RNA polymerase, said RNA virus derived sequence comprising at least cis elements for replication but no gene that codes for viral RNA/RNA polymerase and no gene that codes for viral coat protein. The invention also relates to eukaryotic or prokaryotic cells or organisms which incorporate the recombinant DNA according to the invention. Further, the invention relates to a method of protecting such cells or organisms by genetically incorporating recombinant DNA according to the invention.
A method of inducible production in plants or plant cells of a non-viral sequence of interest selected from the group consisting of proteins, polypeptides and RNAs, comprising
A method of inducible production in tobacco or cowpea plants or plant cells of a non-viral sequence of interest selected from the group consisting of proteins, polypeptides and RNAs, comprising
Dependencies are inferred from the claim text.